Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells

Journal of Neural Transmission

Volumn 119, Issue 1, 2012, Pages 17-24

  Bence, Melinda ^a   Koller, Julia ^a   Sasvari Szekely, Maria ^a   Keszler, Gergely ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Gene expression; Monoamine reuptake transporters; Neurotransmission; Transcriptional regulation; Trichostatin A

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOL METHYLTRANSFERASE; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE RECEPTOR REGULATING FACTOR; DOPAMINE TRANSPORTER; HISTONE DEACETYLASE; MESSENGER RNA; REGULATOR PROTEIN; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; TRICHOSTATIN A; TRYPTOPHAN HYDROXYLASE 2; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; MONOAMINERGIC SYSTEM; NEUROBLASTOMA CELL; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONINERGIC SYSTEM; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

BIOGENIC MONOAMINES; CATECHOL O-METHYLTRANSFERASE; CELL HYPOXIA; CELL LINE, TUMOR; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MONOAMINE OXIDASE; NEUROBLASTOMA; RNA, MESSENGER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION; TIME FACTORS; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857633185     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0688-4     Document Type: Article

References (41)

1. Bence M, Kereszturi E, Mozes V, Sasvari-Szekely M, Keszler G (2009) Hypoxia-induced transcription of dopamine D3 and D4 receptors in human neuroblastoma and astrocytoma cells. BMC Neurosci 10:92
2. Chambers AE, Banerjee S, Chaplin T, Dunne J, Debernardi S, Joel SP, Young BD (2003) Histone acetylation-mediated regulation of genes in leukaemic cells. Eur J Cancer 39:1165-1175 (Pubitemid 36555877)
3. Chen K, Ou XM, Chen G, Choi SH, Shih JC (2005) R1, a novel repressor of the human monoamine oxidase A. J Biol Chem 280:11552-11559 (Pubitemid 40418467)
4. Codd R, Braich N, Liu J, Soe CZ, Pakchung AA (2009) Zn(II)- dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A. Int J Biochem Cell Biol 41:736-739
5. Ellis DJ, Lawman ZK, Bonham K (2008) Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors. Biochem Biophys Res Commun 367:656-662
6. Ellis L, Hammers H, Pili R (2009) Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett 280:145-153
7. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005) Molecular genetics of attentiondeficit/ hyperactivity disorder. Biol Psychiatry 57:1313-1323 (Pubitemid 40798551)
8. Fu J, Weise AM, Falany JL, Falany CN, Thibodeau BJ, Miller FR, Kocarek TA, Runge-Morris M (2010) Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression. Breast Cancer Res Treat 120:35-45
9. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459:55-60
10. Haile CN, Kosten TR, Kosten TA (2009) Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. Am J Drug Alcohol Abuse 35:161-177
11. Heils A, Wichems C, Mössner R, Petri S, Glatz K, Bengel D, Murphy DL, Lesch KP (1998) Functional characterization of the murine serotonin transporter gene promoter in serotonergic raphe neurons. J Neurochem 70:932-939 (Pubitemid 28113625)
12. Heo H, Yoo L, Shin KS, Kang SJ (2009) Suppression of caspase-11 expression by histone deacetylase inhibitors. Biochem Biophys Res Commun 378:79-83
13. Her S, Lee MS, Morita K (2010) Trichostatin A stimulates steroid 5alpha-reductase gene expression in rat C6 glioma cells via a mechanism involving Sp1 and Sp3 transcription factors. J Mol Neurosci 41:252-262
14. Kasper LH, Boussouar F, Boyd K, Xu W, Biesen M, Rehg J, Baudino TA, Cleveland JL, Brindle PK (2005) Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. EMBO J 24:3846-3858 (Pubitemid 41637992)
15. Kawarai T, Kawakami H, Yamamura Y, Nakamura S (1997) Structure and organization of the gene encoding human dopamine transporter. Gene 195:11-18 (Pubitemid 27336955)
16. Kee HJ, Kook H (2009) Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. J Mol Cell Cardiol 47:770-780
17. Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, Moon EJ, Kim HS, Lee SK, Chung HY, Kim CW, Kim KW (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 7:437-443 (Pubitemid 32298546)
18. Kong X, Fang M, Li P, Fang F, Xu Y (2009) HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells. J Mol Cell Cardiol 46:292-299
19. Kouskouti A, Talianidis I (2005) Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO J 24:347-357 (Pubitemid 40216139)
20. Kwon HJ, Kim MS, Kim MJ, Nakajima H, Kim KW (2002) Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. Int J Cancer 97:290-296 (Pubitemid 34049018)
21. Lee KH, Kwak YD, Kim DH, Chang MY, Lee YS, Lee YS (2004) Human zinc finger protein 161, a novel transcriptional activator of the dopamine transporter. Biochem Biophys Res Commun 313:969-976
22. Lin Z, Madras BK (2006) Human genetics and pharmacology of neurotransmitter transporters. Handb Exp Pharmacol 175: 327-371
23. Liu T, Tee AE, Porro A, Smith SA, Dwarte T, Liu PY, Iraci N, Sekyere E, Haber M, Norris MD, Diolaiti D, Della Valle G, Perini G, Marshall GM (2007) Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proc Natl Acad Sci USA 104:18682-18687 (Pubitemid 350210757)
24. Marmorstein R, Trievel RC (2009) Histone modifying enzymes: structures, mechanisms, and specificities. Biochim Biophys Acta 1789:58-68
25. Martínez-Iglesias O, Ruiz-Llorente L, Sánchez- Martínez R, García L, Zambrano A, Aranda A (2008) Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer. Clin Transl Oncol 10:395-398
26. Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ, Kaneda Y (2009) A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature 460: 287-291
27. Park H, Lee YJ, Kim TH, Lee J, Yoon S, Choi WS, Myung CS, Kim HS (2008) Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. Int J Mol Med 22:605-611
28. Qian DZ, Kachhap SK, Collis SJ, Verheul HM, Carducci MA, Atadja P, Pili R (2006) Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha. Cancer Res 66:8814-8821 (Pubitemid 44449199)
29. Romieu P, Host L, Gobaille S, Sandner G, Aunis D, Zwiller J (2008) Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J Neurosci 28:9342-9348
30. Ronacher K, Hadley K, Avenant C, Stubsrud E, Simons SS Jr, Louw A, Hapgood JP (2009) Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction. Mol Cell Endocrinol 299:219-231
31. Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ (2001) Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J Neurochem 76:1565-1572 (Pubitemid 32198260)
32. Samochowiec J, Rybakowski F, Czerski P, Zakrzewska M, Stepień G, Pełka-Wysiecka J, Horodnicki J, Rybakowski JK, Hauser J (2001) Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationship to temperamental dimensions measured by the Temperament and Character Inventory in healthy volunteers. Neuropsychobiology 43: 248-253 (Pubitemid 32467698)
33. Sawa H, Murakami H, Ohshima Y, Murakami M, Yamazaki I, Tamura Y, Mima T, Satone A, Ide W, Hashimoto I, Kamada H (2002) Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. Brain Tumor Pathol 19:77-81 (Pubitemid 36356314)
34. Senese S, Zaragoza K, Minardi S, Muradore I, Ronzoni S, Passafaro A, Bernard L, Draetta GF, Alcalay M, Seiser C, Chiocca S (2007) Role for histone deacetylase 1 in human tumor cell proliferation. Mol Cell Biol 27:4784-4795 (Pubitemid 47016131)
35. Seo HW, Kim EJ, Na H, Lee MO (2009) Transcriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1. FEBS Lett 583:55-60
36. Soutoglou E, Papafotiou G, Katrakili N, Talianidis I (2000) Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins. J Biol Chem 275:12515-12520 (Pubitemid 30241396)
37. Wang J, Bannon MJ (2005) Sp1 and Sp3 activate transcription of the human dopamine transporter gene. J Neurochem 93:474-482 (Pubitemid 40547504)
38. Wang J, Michelhaugh SK, Bannon MJ (2007) Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells. Eur J Neurosci 25:1982-1986 (Pubitemid 46581736)
39. Woo HJ, Lee SJ, Choi BT, Park YM, Choi YH (2007) Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. Exp Mol Pathol 82:77-84 (Pubitemid 46038263)
40. Yang QC, Zeng BF, Shi ZM, Dong Y, Jiang ZM, Huang J, Lv YM, Yang CX, Liu YW (2006) Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. J Exp Clin Cancer Res 25:593-599 (Pubitemid 46170683)
41. Yoo AS, Crabtree GR (2009) ATP-dependent chromatin remodeling in neural development. Curr Opin Neurobiol 19:120-126